Gemtuzumab Ozogamicin With G-CSF, Cladribine, Cytarabine & Mitoxantrone for Untreated AML & High-Grade Myeloid Neoplasm

NCT03531918 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

66

Enrollment

OTHER

Sponsor class

Conditions

Acute Myeloid Leukemia

Interventions

DRUG: Cladribine
DRUG: Cytarabine
DRUG: Gemtuzumab Ozogamicin
BIOLOGICAL: Recombinant Granulocyte Colony-Stimulating Factor
OTHER: Laboratory Biomarker Analysis
DRUG: Mitoxantrone Hydrochloride

Sponsor

Fred Hutchinson Cancer Center

Collaborators

[object Object]